Global shares
HLTH
VanEck Global Healthcare Leaders ETF · VanEck
Around 50 healthcare companies from developed markets — drug makers, biotech firms and medical-equipment companies — held at roughly equal weights.
What the fee costs you
The management fee is 0.45% a year. Here’s what that works out to in dollars:
A 0.45% yearly fee works out to about $45 a year per $10,000 invested.
A rough guide based on the headline fee only. Other costs (such as brokerage or buy/sell spreads) aren’t included.
The basics
- Issuer
- VanEck
- Asset class
- Global shares
- Number of holdings
- ~50
- Where it invests
- Global developed markets, with the US the largest share.
- Income paid
- Annually
- Currency hedged
- No — It's unhedged, so for an Australian investor the value also moves with the Australian dollar against foreign currencies, on top of the shares themselves.
Its character
A global healthcare fund spanning pharmaceuticals, biotech and medical devices, weighted fairly evenly rather than dominated by the largest names. Healthcare demand tends to be relatively steady, but the biotech slice adds a more speculative edge.
What to keep in mind
A single-sector fund, so it leans entirely on healthcare; the biotech slice in particular can be volatile, swinging on trial results and approvals. Unhedged, so currency movements feed through for an Australian holder.
Figures last verified 2026-06-23against the issuer’s factsheet and PDS.